In this study, we sought to extend the validation of this protocol, by verifying if neuroinflammation is induced concomitantly to the other alterations related to PD pathophysiology seen in previous studies (decreased dopaminergic markers, increased alpha-synuclein and oxidative stress). The gene discussed is SNCA; the disease is Parkinson disease.